GenmabGMAB 
$26.20-0.87%24h
-0.87%24h
Global rank998
Market cap$17.11B
Change 7d-
YTD Performance-16.43%
SP500 benchmarkUnderperform
P/E3.97
P/S6.97
Revenue$2.45B
Earnings$648.34M
Dividend yield-
Main Sector
Healthcare
EPS for Genmab (GMAB)
Genmab has an EPS of $6.602. In 2022, the company made an earnings per share (EPS) of $8.259. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for GMAB
-
Value:-
EPS history for Genmab from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $6.60 | -20.06% |
| 2022 | $8.26 | 84.48% |
| 2021 | $4.48 | -38.00% |
| 2020 | $7.22 | - |
View the highest EPS stocks
